-+ 0.00%
-+ 0.00%
-+ 0.00%

ATYR PHARMA INC: TO CONTINUE DEVELOPMENT OF EFZOFITIMOD IN PULMONARY SARCOIDOSIS INCORPORATING FDA FEEDBACK

Reuters·05/11/2026 20:01:00

Please log in to view news